|
|
||||||||
and
tumor necrosis factor-
Vascular Biology Research Centre, Biomedical Sciences Division, King's College London, Kensington, London W8 7AH, United Kingdom
Work from this and other laboratories has identified a role for
protein tyrosine kinases in interleukin-1
(IL-1
)- and tumor necrosis factor-
(TNF-
)-induced responses in endothelial cells. In this study, we show that activation of human umbilical vein endothelial cells (HUVEC) by IL-1
leads to increased tyrosine phosphorylation of several proteins including one with a molecular mass
of ~42 kDa. This protein was identified as
p42mapk by Western blot analysis.
Tyrosine phosphorylation and catalytic activation of
p42mapk by IL-1
was transient,
reaching maximal levels after 30 min and returning to basal levels by
120-300 min. Activation of
p42mapk in HUVEC was also observed
in response to TNF-
or to the protein kinase C (PKC)-activating
phorbol ester phorbol 12-myristate 13-acetate (PMA). Pretreatment of
HUVEC with IL-1
or TNF-
prevented reactivation of
p42mapk by either cytokine but did
not affect subsequent activation in response to PMA. Activation of
p42mapk by PMA was significantly
reduced by the PKC inhibitor Ro-31-8220 and completely inhibited by the
protein tyrosine kinase inhibitor genistein. Genistein, but not
Ro-31-8220, attenuated IL-1
- and TNF-
-induced
p42mapk activation. Taken
together, the results of this study demonstrate 1) that
p42mapk is transiently activated
in HUVEC by IL-1
and TNF-
, 2)
that this activation is PKC independent, and
3) that a genistein-inhibitable tyrosine kinase may be an upstream regulator of cytokine-induced p42mapk activation in human
endothelium.
cytokines; signal transduction; protein kinases; phosphatases
This article has been cited by other articles:
![]() |
A. Papapetropoulos, S. Andreopoulos, C. Y. Go, A. Hoque, L. C. Fuchs, and J. D. Catravas Regulation of the nitric oxide synthase-nitric oxide- cGMP pathway in rat mesenteric endothelial cells J Appl Physiol, December 1, 2001; 91(6): 2553 - 2560. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oshima, K. P. Pavlick, F. S. Laroux, S. K. Verma, P. Jordan, M. B. Grisham, L. Williams, and J. S. Alexander Regulation and distribution of MAdCAM-1 in endothelial cells in vitro Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1096 - C1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Houliston, J. D. Pearson, and C. P. D. Wheeler-Jones Agonist-specific cross talk between ERKs and p38mapk regulates PGI2 synthesis in endothelium Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1266 - C1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hu, J.-M. Kiely, B. E. Szente, A. Rosenzweig, and M. A. Gimbrone Jr. E-Selectin-Dependent Signaling Via the Mitogen-Activated Protein Kinase Pathway in Vascular Endothelial Cells J. Immunol., August 15, 2000; 165(4): 2142 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. O'Brien, N. Prevost, M. Molino, M. K. Hollinger, M. J. Woolkalis, D. S. Woulfe, and L. F. Brass Thrombin Responses in Human Endothelial Cells. CONTRIBUTIONS FROM RECEPTORS OTHER THAN PAR1 INCLUDE THE TRANSACTIVATION OF PAR2 BY THROMBIN-CLEAVED PAR1 J. Biol. Chem., April 28, 2000; 275(18): 13502 - 13509. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |